Assimilating new therapeutic interventions into clinical practice: How does hypertension compare with other therapeutic areas?

American Heart Journal

Volumn 138, Issue 3 II, 1999, Pages

  Carruthers, S G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; WARFARIN;

ANTIHYPERTENSIVE THERAPY; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 0032844539     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70319-4     Document Type: Review

References (27)

1. McInnes GT. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999;138:S252-5.
2. Beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA 1982;247:1707-14.
3. Beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction, II: morbidity results. JAMA 1983;250:2814-9.
4. Pedersen TR. The Norwegian Multicenter Study of Timolol after Myocardial Infarction. Circulation 1983;67:149-53.
5. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175-9.
6. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991;84:527-39.
7. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
8. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators [published erratum appears in N Engl J Med 1993 Jan 14;328:148]. N Engl J Med 1992;327:1406-12.
9. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): the CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators. N Engl J Med 1991;325:293-302.
11. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: the SOLVD Investigators [Erratum appears in N Engl J Med 1992 Dec 10;327:1768]. N Engl J Med 1992;327:685-91.
12. Konstam MA, Rousseau MF, Kronenberg MW, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure: SOLVD Investigators. Circulation 1992;86:431-8.
13. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial: the SAVE Investigators [see comments]. N Engl J Med 1992;327:669-77.
14. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA 1995;273:1450-6.
15. Karlson BW, Herlitz J, Hjalmarson A. Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate. Clin Cardiol 1994;17:311-6.
16. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med 1996;11:713-20.
17. Parmley WW. Cost-effective management of heart failure. Clin Cardiol 1996;19:240-2.
18. The Clinical Quality Improvement Network (CQIN) Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure: the relative importance of age, sex, and medical therapy. Arch Intern Med 1996;156:1669-73.
19. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure [see comments]. Arch Intern Med 1997;157:2460-4.
20. Swales JD. Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation-Regional and Global) project. Am Heart J 1999;138:S231-7.
21. McAlister FA, Teo KK, Lewanczuk RZ, et al. Contemporary practice patterns in the management of newly diagnosed hypertension [see comments]. Can Med Assoc J 1997;157:23-30.
22. Tamblyn R, Battista R. Changing clinical practice: which interventions work? J Continuing Education Health Professions 1996;13:273-88.
23. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995;153:1423-31.
24. Wensing M, van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998;48:991-7.
25. Goldberg HI, Wagner EH, Fihn SD, et al. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines? Jt Comm J Qual Improv 1998;24:130-42.
26. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.
27. Montague T, Taylor L, Martin S, et al. Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine: the Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol 1995;11:487-92.